Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colostrum Supplements in Healthy Subjects and Type 2 Diabetes
NCT06549556Phase 2Completed
- Sponsor
- Al-Rasheed University College
- Start
- Aug 2024
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 2, randomised trial (4 arms), sponsored by Al-Rasheed University College. Primary endpoints: Serum Interleukin-1 Level at 60 days, Serum Interleukin-15 Level at 60 days and 3 more. Started Aug 2024; status: completed.
Beyond the preview
Go deeper on NCT06549556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06549556.